Syros Pharmaceuticals, Inc.
Pyrrolotriazine compounds and methods of inhibiting TAM kinases

Last updated:

Abstract:

Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat cancer.

Status:
Grant
Type:

Utility

Filling date:

9 Oct 2018

Issue date:

22 Jun 2021